Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia

Journal of Periodontology

Volumn 70, Issue 11, 1999, Pages 1313-1321

  Cutler, Christopher W ^a,b   Machen, Robert L ^a   Jotwani, Ravi ^a   Iacopino, Anthony M ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

^b Araraquara College of Dentistry   (United States)

Author keywords

Clinical research; Controlled clinical trials; Diabetes complications; Gingiva; Hyperlipidemia complications; Periodontitis complications

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPID; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; PLATELET-DERIVED GROWTH FACTOR AB;

ADULT; ARTICLE; BLOOD; CHEMISTRY; GINGIVA; GINGIVITIS; HUMAN; HYPERLIPIDEMIA; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTAL DISEASE; PERIODONTICS; TOOTH PLAQUE;

ADULT; DENTAL PLAQUE INDEX; DIABETES MELLITUS, TYPE 2; GINGIVA; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; INTERLEUKIN-1; INTERLEUKIN-6; LIPIDS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PLATELET-DERIVED GROWTH FACTOR;

EID: 0033228715     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1999.70.11.1313     Document Type: Article

References (49)

1. Smith JT, Douglass FR. Diabetes Vital Statistics. Washington, DC: U.S. Department of Health and Human Services; 1993:1-9.
2. Gary A. Lipid lowering therapy and microvascular disease in diabetics. Diabetes 1992;41:111-115.
3. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991;62:123-130.
4. Katz PP, Wirthlin MR Jr., Szpunar SM, Selby JV, Sepe SJ, Showstack JA. Epidemiology and prevention of periodontal disease in individuals with diabetes. Diabetes Care 1991;14:375-385.
5. Shlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990;121:532-536.
6. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary artery disease and mortality. Br Med J 1993;306:688-691.
7. Beck JD, Offenbacher S, Williams R, Gibbs R, Garcia R. Periodontitis: A risk factor for coronary heart disease? Ann Periodontol 1998;3:127-141.
8. Howard BV, Schniederman N, Falkner B, Laws A. Insulin, health behaviors, and lipid metabolism. Metabolism 1993;36:1-8.
9. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation end products: Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994;14:1521-1528.
10. Cutler CW. Serum Mediated Interactions Between Bacteroides gingivalis and Polymorphonuclear Leukocytes [doctoral thesis]. Atlanta, GA: Emory university; 1990.
11. Salvi GE, Yalda B, Collins JG, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997;68:127-135.
12. Hafstrom I, Ringertz B, Gyllenhammer H, Palmblad J, Harms-Ringdahl M. Effects of fasting on disease activity, neutrophil function, fatty acid composition and leukotriene biosynthesis in patients with rheumatoid arthritis. Arthritis Rheum 1988;31:585-592.
13. Clarke SD, Jump DB. Regulation of gene transcription by polyunsaturated fatty acids. Prog Lipid Res 1993; 32:139-149.
14. Doxey DL, Cutler CW, lacopino AM. Diabetes prevents periodontitis-induced increases in gingival platelet derived growth factor-B and interleukin 1-beta in a rat model. J Periodontol 1998;69:113-119.
15. Pickup JC, Crook MA, Tutt P. Blood glucose and glycated hemoglobin measurement in hospital: Which method? Diabetic Med 1993;10:402-411.
16. Löe H, Silness J. Periodontal disease and pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-551.
17. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal control. Acta Odontol Scand 1964;22:121-135.
18. Chaves ES, Wood RC, Jones AA, Newbold DA, Manwell MA, Kornman KS. Relationship of bleeding on probing and gingival index bleeding as clinical parameters of gingival inflammation. J Clin Periodontol 1993; 20:139-143.
19. Gibbs CH, Hirschfeld JW, Lee JG, Low SB, Magnusson I. Description and clinical evaluation of a new computerized periodontal probe: The Florida Probe. J Clin Periodontol 1988;15:137-144.
20. Cutler CW, Doxey D, lacopino AM. The detection of increased crevicular fluid IL-1β levels in subclinical gingivitis. J Dent Res 1997;76(Spec. Issue): 440 (Abstr. 3415).
21. Tervonen T, Oliver R. Long-term control of diabetes mellitus and periodontitis. J Clin Periodontol 1993; 20:431-435.
22. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986; 21:101-112.
23. Masada MP, Persson R, Kenny JS, Lee SW, Page RC, Allison MC. Measurement of interleukin-1 alpha and beta in gingival crevicular fluid: Implications for the pathogenesis of periodontal disease. J Periodont Res 1990;25:156-163.
24. Page R. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991;26:230-242.
25. Manouchehr-Pour M, Spagnuolo P, Rodman H, Bissada N, Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res 1981;60:729-731.
26. 2, IL-1 beta and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 1998; 3:40-50.
27. Memon RA, Grunfeld C, Moser AH, Feingold KR. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 1993;132:2246-2253.
28. Eggesbo JB, Hjermann I, Hostmark AT, Kierulf P. LPS-induced release of IL-1β, IL-6, IL-8 and TMF-alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine 1996;8:152-160.
29. Ciampolillo A, Guastamacchia E, Caragiulo L, et al. In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients. Diabetes Res Clin Pract 1993; 21:87-93.
30. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin-1 beta in tissue from sites of active periodontal disease. J Clin Periodontol 1991;18:548-554.
31. Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996;67(Suppl.):1103-1113.
32. Reimers JI. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus? Danish Med Bull 1998;45:157-180.
33. Williams R, Mahan C. Periodontal disease and diabetes in young adults. JAMA 1960;172:776-778.
34. Mooradian AD, Reed RL, Meridith KE, Scuderi P. Serum levels of tumor necrosis factor and IL-1 alpha and IL-1 beta in diabetic patients. Diabetes Care 1991;14:63-65.
35. Tsukaguchi K, Toneda T, Yoshikawa M, et al. Case study of interleukin-1 beta, tumor necrosis factor alpha and interleukin-9 production of peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis. Kekkaku 1992;67:755-760.
36. Doxey DL, Nares S, Park B, Trieu C, Cutler CW, lacopino AM. Diabetes-induced impairment of macrophage cytokine release in a rat model: Potential role of serum lipids. Life Sci 1998;63:1127-1136.
37. lacopino AM. Diabetic periodontitis: Possible lipid-induced defect in tissue repair through alteration of macrophage phenotype and function. Oral Dis 1995;1:214-229.
38. Uhlinger DJ, Cutler CW, Arnold RR, Lambeth JD, Merrill AH. Functional differences in human neutrophils isolated pre and post-prandially. Fed Eur Biochem Soc 1991;286:28-32.
39. Ishimi Y, Miyara C, Jin CH. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;15:3297-3303.
40. Kurihara N, Civin C, Roodman GD. Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res 1991;6:257-261.
41. 2 inhibits interleukin-6 release but not its transcription in human gingival fibroblasts stimulated with interleukin-1β or tumor necrosis factor-α. J Periodontol 1994;65:1122-1127.
42. Nelson RG, Shlossman M, Budding LM, et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990;13:836-840.
43. Saftkan-Seppäla B, Ainamo J. Periodontal conditions in insulin-dependent diabetes mellitus. J Clin Periodontol 1992;19:24-29.
44. Cohen MP. Non-enzymatic glycosylation. Diabetes Ann 1988;4:469-484.
45. Gisle G, Nilsson KO, Matsson L. Gingival inflammation in diabetic children related to degree of metabolic control. Acta Odontol Scand 1980;38:201-209.
46. Messadi DV, Bertolami CN. General principles of healing pertinent to the periodontal problem. Dent Clin North Am 1991;35:443-457.
47. Cross M, Dexter TM. Growth factors in development, transformation, and tumorigenesis. Cell 1991;64:271-280.
48. Doxey DL, Dill RE, lacopino AM. Platelet-derived growth factor levels in wounds of diabetic rats. Life Sci 1995;57:1111-1123.
49. Plemons JM, Russell ED, Rees TD, Dyer BJ, Ng MC, lacopino AM. PDGF-B producing cells and PDGF-B gene expression in normal gingiva and cyclosporine A-induced gingival overgrowth. J Periodontol 1996;67:264-270.